Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4578 and Opdivo with mFOLFOX6 and Bevacizumab in Advanced Colorectal Cancer
NCT06948448Phase 2Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Nov 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of ONO-4578 in colorectal cancer (CRC), sponsored by Ono Pharmaceutical. Started Nov 2025; status: recruiting.
02
Drugs
ONO-4578
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06948448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06948448.